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 T cell–induced hyaluronan production by 
epithelial cells regulates inﬂammation
 
Julie M. Jameson, Gabrielle Cauvi, Leslie L. Sharp, Deborah A. Witherden, 
 
and Wendy L. Havran
 
The Scripps Research Institute, La Jolla, CA 92037
 
Nonhealing wounds are a major complication of diseases such as diabetes and rheumatoid 
arthritis. For efficient tissue repair, inflammatory cells must infiltrate into the damaged 
tissue to orchestrate wound closure. Hyaluronan is involved in the inflammation associated 
with wound repair and binds the surface of leukocytes infiltrating damaged sites. Skin 
 
  
 
 T cells 
play specialized roles in keratinocyte proliferation during wound repair. Here, we show that 
 
  
 
 T cells are required for hyaluronan deposition in the extracellular matrix (ECM) and 
subsequent macrophage infiltration into wound sites. We describe a novel mechanism of 
control in which 
 
  
 
 T cell–derived keratinocyte growth factors induce epithelial cell 
production of hyaluronan. In turn, hyaluronan recruits macrophages to the site of damage. 
These results demonstrate a novel function for skin 
 
  
 
 T cells in inflammation and provide a 
new perspective on T cell regulation of ECM molecules.
 
Wound repair is a multifaceted biological process
that involves the participation of numerous cell
types and factors to accomplish the three
phases of wound healing: inflammation, tissue
formation, and tissue remodeling. Skin 
 
  
 
 T
cells, also called dendritic epidermal T cells
(DETC), are a prototypical 
 
  
 
 intraepithelial
lymphocyte (IEL) that recognize an, as yet un-
identified, antigen expressed by damaged,
stressed, or transformed keratinocytes in the
epidermis (for reviews see references 1, 2).
These intraepithelial 
 
  
 
 T cells are thought to
provide a first line of defense through the rec-
ognition of self-antigens expressed on damaged
or stressed cells. Although the exact nature of
the stress-induced keratinocyte antigen is un-
known, it induces DETC to proliferate via the
canonical V
 
 
 
3 V
 
 
 
1 TCR (2). DETC play
roles in keratinocyte proliferation during wound
repair (3), epithelial cell homeostasis (4), and
have been implicated in contact hypersensitiv-
ity (5), however, their roles in inflammation
and extracellular matrix (ECM) modulation
are unknown.
Rapid and complete wound repair cannot
occur without the infiltration of peripheral
leukocytes into the wound site to help stave
off infection, break-down tissue, and regenerate
the epidermis (6–11). The first of these leuko-
cytes are neutrophils, which are rapidly re-
cruited within 1 d of injury, and are one of the
most abundant inflammatory cell types at this
time-point (12). Macrophages, essential to the
normal wound repair process, enter the site 3 d
after injury (13–15). Macrophages phagocytose
debris, produce extracellular matrix molecules,
and secrete growth factors at the wound site
(6, 16). Lymphocytes enter the dermis near the
wound by day 7 and are the most common in-
flammatory cell at the wound site 14 d after
injury (12). Defects in inflammation can de-
stroy the delicate balance of these cell types
and soluble factors necessary for complete wound
repair.
Glycosaminoglycans (GAGs) are a major
component of connective tissue and are regularly
present in healing wounds. They commonly
bind the cell surface of infiltrating leukocytes
that migrate into the damaged site and play
several functional roles in the inflammation asso-
ciated with wound repair (17). It has been re-
ported that GAG binding is not necessary for
chemokine action, but it can augment the activ-
ity of low levels of chemokines (18). One of
the best characterized GAGs is hyaluronan or
hyaluronic acid, which is produced by many
different cell types and is heavily distributed in
the ECM during wound repair (19). Hyaluronan
binds cell surface receptors including CD44
(20) and has been shown to play a key role in
the inflammatory cell migration associated with
wound repair (21). Addition of hyaluronan to
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acute membrane perforations accelerated the closure of the
wounds in rats (22). Furthermore, hyaluronan oligomers
have been shown to activate endothelial cells and dendritic
cells via TLR4, which may be important for inflammation
(23, 24). The role of T cells in hyaluronan deposition is un-
known, but it may be used by resident T cells to regulate
cellular infiltration (25).
Hyaluronan polysaccharides are extruded into the extra-
cellular space simultaneous with their synthesis at the inner
surface of the plasma membrane by three hyaluronan syn-
thases (HAS), HAS 1–3 (26). The HAS genes are essential
(27) and highly conserved (26). Several reports have shown
that even though murine HAS 1–3 share 55–71% sequence
identity, they present distinct patterns of expression and re-
lated but distinct enzymatic properties (26). Their functions
are still being investigated, but it is known that they produce
different sizes of hyaluronan. HAS 1 and 2 synthesize 200–
2,000-kD HA polysaccharides and HAS 3 produces smaller
size polymers of 40–100 kD (26). Their elongation rates are
also different with HAS 1 being the fastest and HAS 3 being
the slowest (28). Overexpression of HAS 2 in keratinocytes
confers the ability to control their migration toward empty
space or an in vitro wound site (29). Such functions for HAS
1 and HAS 3 have not been studied. Keratinocyte growth
factor-1 (FGF-7), which is produced by DETC after activa-
tion and during wound repair (3, 30), binds the FGFR2-IIIb
receptor expressed by keratinocytes and upon binding in-
creases hyaluronan synthesis through HAS 2 and HAS 3 up-
regulation (31).
To determine whether resident DETC play a role in hy-
aluronan deposition and inflammation we monitored the in-
filtration of leukocytes after full-thickness wounding of mice
lacking 
 
  
 
 DETC, TCR
 
 
 
 
 
/
 
 
 
 mice. We provide evidence
that DETC play a critical regulatory role in early inflamma-
tion during wound repair by inducing keratinocytes to pro-
duce hyaluronan. Furthermore, DETC have the capacity to
make hyaluronan themselves. We show that the hyaluronan,
in turn, directs macrophages to the wound site. These results
demonstrate a novel function for skin 
 
  
 
 T cells in inflam-
mation, involving a mechanism that provides a new perspec-
tive on the role of T cells in the regulation of ECM mol-
ecule production. This induction of epithelial cell gene
expression by 
 
  
 
 T cells, demonstrates the importance of
these cells in tissue maintenance and homeostasis.
 
RESULTS
 
  
 
 T cells are not required for rapid neutrophil migration 
to wounded skin
 
Inflammatory cells make their way to the epidermal com-
partment via the blood stream. The recruited cells traverse
into the hypodermis of the skin via blood vessels. Next they
migrate up out of the hypodermis into the reticular dermis,
finally passing the dermal papillae into the epidermis. To de-
termine if skin 
 
  
 
 T cells play a role in this recruitment,
TCR
 
 
 
 
 
/
 
 
 
 mice were wounded and observed for defects in
inflammatory cell infiltration. Neutrophils are one of the first
cell populations to enter wild-type wound sites, usually infil-
trating within 12 h and exiting via the scab by day 3 (12).
Neutrophil migration into the wound site of TCR
 
 
 
 
 
/
 
 
 
mice was examined in paraffin sections using antibodies spe-
cific for the Gr-1 marker. Neutrophils entered rapidly by
day 1 after wounding in both wild-type and TCR
 
 
 
 
 
/
 
 
 
 mice
and were observed in the hypodermis, dermis, and epidermis
(Fig. 1, A and B). The dark Gr-1 staining around the scab
and directly next to the wound site was of similar intensity in
the wild-type and TCR
 
 
 
 
 
/
 
 
 
 mice (Fig. 1, A and B). Sec-
tions examined at 6 and 12 h likewise showed no difference
in Gr-1 staining (unpublished data). Positive cells were no
longer evident by day 5 in either mouse strain (unpublished
data). No differences in the timing of neutrophil entry or
exit from the wound site were detected between TCR
 
 
 
 
 
/
 
 
 
and wild-type mice.
 
In the absence of 
 
  
 
 T cells, mice have defects in 
macrophage homing to damaged skin
 
To examine the role of skin 
 
  
 
 T cells in the migration of
macrophages to the damaged site, skin sections from wounded
and nonwounded wild-type and TCR
 
 
 
 
 
/
 
 
 
 mice were
stained with antibodies specific for either MHC class II or
the macrophage marker, F4/80 (Fig. 1, C–J). Sections di-
rectly adjacent to the wound were examined to compare the
degree of inflammation in wild-type and TCR
 
 
 
 
 
/
 
 
 
 mice.
MHC class II and F4/80-positive cells were delayed in en-
tering the wound site of TCR
 
 
 
 
 
/
 
 
 
 mice as compared with
wild-type mice. In wild-type mice, large numbers of MHC
class II–positive cells were detected from the hypodermis up
to the dermis directly beneath the hyperthickened, damaged
epidermis by day 3 (Fig. 1 C). By day 5, the cells expressing
MHC class II accumulated in great numbers just under the
damaged epidermis and throughout the entire dermis (un-
published data). In contrast, wounds isolated from TCR
 
 
 
 
 
/
 
 
 
mice had virtually no MHC class II–expressing cells in the
dermis on day 3 after injury (Fig. 1 D) and those that entered
on day 5 remained in the hypodermis (unpublished data).
Large numbers of MHC class II–expressing cells finally en-
tered the dermis around the wound site by day 7 in TCR
 
 
 
 
 
/
 
 
 
mice (unpublished data).
To further characterize the MHC class II–positive infil-
trating population, an anti-F4/80 antibody was used to de-
tect macrophages. Macrophages were largely absent from
nonwounded tissue in wild-type and TCR
 
 
 
 
 
/
 
 
 
 mice (Fig.
1, E and F). 3–5 d after injury, massive macrophage infiltra-
tion dominates the dermis near the wound site of wild-type
mice (Fig. 1, G and I), whereas very few macrophages enter
the dermis of TCR
 
 
 
 
 
/
 
 
 
 mice at this time (Fig. 1, H and J).
These results indicate that macrophages are the major MHC
class II–positive population infiltrating these wounds.
We quantified the number of F4/80-positive cells in the
hypodermis or upper dermis of the wound site from wild-
type and TCR
 
 
 
 
 
/
 
 
 
 skin sections (Fig. 1, K and L). These re- 
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sults indicate that macrophages enter the hypodermis of
wild-type mice in great numbers by day 1 after wounding,
whereas the numbers of macrophages entering TCR
 
 
 
 
 
/
 
 
 
skin slowly increase until day 5 when they finally reach wild-
type levels (Fig. 1 K). The macrophages that infiltrate the
wounded TCR
 
 
 
 
 
/
 
 
 
 skin are located deep in the hypoder-
Figure 1.    T cells are required for the rapid migration of mac-
rophages, but not neutrophils, into the wound site. Nonwounded and 
wounded skin from wild-type (A, C, E, G, and I) and TCR  /  (B, D, F, H, and 
J) mice were embedded in paraffin and 5  m sections cut for immunohis-
tochemistry. Shown are sections stained with antibodies specific for Gr-1 
on day 1 after wounding (A and B), MHC class II on day 3 after wounding 
(C and D), F4/80 on nonwounded sections (E and F), F4/80 on day 3 after 
wounding (G and H), or F4/80 on day 5 after wounding (I and J). The epider-
mis is oriented on the top and images represent the area directly adjacent 
to the wound site. Epidermis (e), dermis (d), hypodermis (h), and eschar (es) 
are labeled. Representative positive cells are marked by arrows. Digital 
images of representative wound sites were acquired ( 200). Macrophage 
infiltration of the hypodermis (K) or upper dermis (L) of wild-type (solid 
bars) or TCR  /  (open bars) mice was quantified by enumerating F4/80-
positive cells in 1,000  fields. Error bars represent the SD. 
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mis, unlike wild-type mouse skin in which macrophages in-
filtrate the entire hypodermis of the wound. In wild-type
mice, macrophages leave the hypodermis for the upper der-
mal compartment by day 3, however, few F4/80-positive
cells are found in the TCR
 
 
 
 
 
/
 
 
 
 mouse at this time-point
(Fig. 1 L). Taken together our results indicate that there is at
least a 4-d delay in macrophage infiltration of wounds in the
absence of 
 
  
 
 T cells.
 
Hyaluronan deposition is defective at the wound site of 
TCR
 
 
 
 
 
/
 
 
 
 mice
 
To investigate the mechanism involved in this delay in mac-
rophage infiltration, we examined GAG deposition in the
mouse wounds. GAGs play important roles in macrophage
migration. Some GAGs are sulfated (dermatan sulfate, chon-
droitin sulfate, heparin sulfate), whereas others are not (hy-
aluronan). Wounded skin was excised from wild-type or
TCR
 
 
 
 
 
/
 
 
 
 mice at various time-points. The wound sites
were examined using alcian blue, pH 3.0, staining, which is
commonly used to detect both neutral and sulfated GAGs.
As expected, in nonwounded skin there was light alcian blue
staining indicating that there is a low level of constitutive
GAG expression in the ECM (Fig. 2, A and B). In wild-type
mice, 3-d-old wounds had intense alcian blue staining di-
rectly under the wound site emanating from the damaged
area (Fig. 2 C). By day 5 after wounding the level of staining
in wild-type skin decreased and was contained in the hypo-
dermis (unpublished data). In contrast, the 
 
  
 
-deficient
mouse skin displayed less intense alcian blue staining re-
stricted to the hypodermis near the wound site 3 d after in-
jury indicating reduced GAG expression (Fig. 2 D). By day 5
after wounding, the alcian blue staining in the TCR
 
 
 
 
 
/
 
 
 
skin intensifies under the injured site, appearing at levels
similar to the wild-type day 3–wounded skin but less local-
ized (unpublished data). This delay in GAG expression is
consistent with the delay in macrophage entry (Fig. 1) and
the delay in wound repair we have previously reported for
mice lacking 
 
  
 
 DETC (3).
Figure 2. Decreased levels of hyaluronan are deposited in the ECM 
of TCR  /  mice 3 d after wounding. Alcian blue staining was performed 
on 5  m paraffin sections from nonwounded (A and B) or day 3 (C and D) 
wild-type (A and C) and TCR  /  (B and D) mouse wounds. Blue stain rep-
resents GAG deposition. To identify the GAG as hyaluronan, biotinylated 
hyaluronan binding protein was used to stain wild-type (E) or TCR  /  (F) 
day 3–wounded skin. Wild-type (G–L) or TCR  /  (not depicted) wounded 
skin was preincubated with or without testicular (G and H) or Streptomyces 
(I–L) hyaluronidase to further identify hyaluronan as the main GAG com-
ponent stained by alcian blue (G–J) or biotinylated hyaluronan binding 
protein (K and L) during this time-point after injury. The epidermis is 
oriented to the top and images represent the area directly adjacent to the 
wound site. Epidermis (e), dermis (d), and eschar (es) are labeled. Digital 
images of representative wound sites were acquired at  100 (A–D) or 
 200 (E–L) magnification. Experiments were performed at least three 
times using three to five mice of each strain per time-point. 
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In wild-type mice, hyaluronan is heavily distributed at
the wound site soon after tissue damage (21). To determine
whether hyaluronan is the key GAG distributed in wild-type
wounds 3 d after injury, a biotinylated hyaluronan binding
protein was used to stain skin sections. Hyaluronan was de-
tected in similar regions of the wounded skin as the alcian
blue (Fig. 2 E). Staining with the hyaluronan binding protein
confirmed a defect in hyaluronan deposition in TCR
 
 
 
 
 
/
 
 
 
mice (Fig. 2 F). Furthermore, addition of either testicular
(Fig. 2 H) or 
 
Streptomyces
 
 (Fig. 2, J and L) hyaluronidase to
the skin sections before staining with alcian blue or hyaluro-
nan binding protein diminished staining intensity to back-
ground levels. The low levels of GAGs observed in the hy-
podermis of TCR
 
 
 
 
 
/
 
 
 
 day 3–wounded skin can also be
digested by either type of hyaluronidase (unpublished data).
Taken together these results suggest that the GAGs distrib-
uted in wild-type skin 3 d after wounding are mostly com-
posed of hyaluronan (Fig. 2, G-L), thus the TCR
 
 
 
 
 
/
 
 
 
 mice
have at least a 2-d delay in hyaluronan deposition directly at
the wound site. Hyaluronan is known to enhance cellular
infiltration during wound repair (32), and as such may con-
tribute to macrophage migration to the wound site.
 
TCR
 
 
 
 
 
/
 
 
 
 mice have impaired hyaluronan synthase expression 
in the epidermis 1 d after wounding
 
HAS 1–3 synthesize hyaluronan at the plasma membrane
and HAS expression correlates with increased levels of hy-
aluronan (26). To identify whether the defect in hyaluronan
deposition observed in TCR
 
 
 
 
 
/
 
 
 
 mice was due to de-
creased production by epidermal cells, we examined HAS
expression levels in the epidermis after wounding in wild-
type and TCR
 
 
 
 
 
/
 
 
 
 skin (Fig. 3). Epidermis was isolated
from the wounds of mice, RNA was extracted, and semi-
quantitative RT-PCR for each HAS was performed. Mice
lacking 
 
  
 
 T cells have decreased levels of HAS 1 at 12 h
and 1 d after wounding and decreased levels of HAS 2 and 3
at 1 d after wounding as compared with wild-type mice.
Using densitometry, HAS gene expression was corrected for
 
 
 
-actin expression and wild-type HAS 1–3 expression was
found to be 1.35, 1.5, and 1.46 times greater, respectively,
than the TCR
 
 
 
 
 
/
 
 
 
 expression at day 1 after wounding.
These results indicate that there is a defect in epidermal cell
HAS expression during wound repair in TCR
 
 
 
 
 
/
 
 
 
 mice,
which may result in decreased hyaluronan deposition at the
wound site.
Hyaluronan is digested by hyaluronidases, therefore it is
possible that the defect in hyaluronan deposition in TCR
 
 
 
 
 
/
 
 
 
skin is due to increased levels of hyaluronidases. Therefore
we examined hyaluronidase expression in wounded TCR
 
 
 
 
 
/
 
 
 
mouse epidermis. There were decreased levels of hyalu-
ronidase 1 expression, similar levels of hyaluronidase 3 ex-
pression, and increased levels of hyaluronidase 2 expression
in the epidermis of TCR  /  mice as compared with wild-
type mice (Fig. S1). Thus the defect in hyaluronan deposi-
tion in the TCR  /  mice does not appear to be caused by a
marked up-regulation in hyaluronidases. However, the in-
creased hyaluronidase 2 expression may further exacerbate
the defect in hyaluronan deposition.
To determine whether the defect in epidermal cell HAS
expression during wound repair is mediated by the kerati-
nocytes, skin    T cells, or both, we examined HAS gene
expression in vitro. We first studied whether DETC express
HAS 1, 2, or 3 upon TCR stimulation.    T cells have
been reported to express HAS 1 and 3 constitutively (33).
We examined RNA from the skin    T cell line, 7–17, for
HAS expression using RT-PCR. 7–17 DETC express HAS
1 and 3, and this expression is inducible upon stimulation
with antibodies specific for the CD3 complex (Fig. 4 A).
HAS 1 expression is up-regulated within 30 min after stimu-
lation and is maximally expressed by 1 h. HAS 3 is up-regu-
lated by 30 min after stimulation with sustained expression
until 2.5 h (Fig. 4 A). DETC-expressed HAS 1 and 3 may
partially account for the defect in HAS expression during
wound repair in TCR  /  mice. However, HAS 2 does not
appear to be expressed by DETC (Fig. 4 A) and because
there are decreased levels of HAS 2 expression in the
TCR  /  epidermis (Fig. 3), we examined whether DETC
up-regulate HAS expression by keratinocytes.
DETC induce keratinocytes to synthesize hyaluronan through 
keratinocyte growth factors
We next used a transwell coculture assay to test the impact
of DETC on hyaluronan synthase expression by kerati-
nocytes. 7–17 DETC were seeded in the inserted transwell,
whereas the keratinocyte cell line, PAM, was cultured in
the bottom chamber. The PAM keratinocytes were incu-
bated alone, with resting 7–17 DETC, or with anti-CD3–
activated 7–17 DETC. After 8 h of coculture PAM kerati-
Figure 3. TCR  /  mice have defects in HAS expression in the epi-
dermis 1 d after wounding. Epidermis was isolated from nonwounded 
skin or at various times after wounding from wild-type or TCR  /  mice. 
RNA was isolated and RT-PCR for HAS 1–3 performed. cDNA was diluted 
1:10 for semiquantitation and compared with  -actin housekeeping gene 
levels. Using densitometry (Adobe Photoshop), HAS gene expression was 
corrected for  -actin expression and wild-type HAS 1–3 expression was 
1.35, 1.5, and 1.46 times greater, respectively, than TCR  /  1 d after 
wounding. These results are representative of at least three separate 
experiments with reproducible results.DETC MODULATE GAGS TO AUGMENT INFLAMMATION | Jameson et al. 1274
nocytes were harvested, RNA was isolated, and RT-PCR
was performed to detect the levels of HAS expression. Low
to undetectable levels of HAS genes were detected in kera-
tinocytes grown without DETC in the insert suggesting
that the keratinocytes do not express much HAS 1–3 con-
stitutively (Fig. 4 B). This correlates with the low to unde-
tectable levels of HAS expression observed in nonwounded
skin (Fig. 3). However, resting DETC stimulate PAM to
express low levels of all three HAS genes, whereas activated
DETC stimulated even greater expression of HAS 2 and 3
(Fig. 4 B). Transwell experiments were also performed us-
ing a fluorescent-labeled hyaluronan binding protein. Hy-
aluronan was detected at higher levels in keratinocytes cul-
tured with DETC (Fig. 5, B and C) as compared with
keratinocytes cultured without DETC (Fig. 5 A). This
staining is diminished to background levels with the addi-
tion of Streptomyces hyaluronidase. Taken together these re-
sults demonstrate that DETC induce HAS expression and
subsequent HA production by keratinocytes. This high-
lights a new role for    T cells in the regulation of epithe-
lial cells.
A likely candidate for the induction of HAS 2 and 3 is
FGF-7. This growth factor has recently been shown to in-
duce HAS 2 and 3 expression in rat keratinocytes (31). FGF-7
and keratinocyte growth factor-2 (FGF-10) bind the same
receptor expressed on keratinocytes, FGFR2IIIb (34–36).
Both factors are produced by DETC upon TCR stimulation
and act in a paracrine fashion on keratinocytes (3, 30).
DETC-produced keratinocyte growth factors play a key role
in keratinocyte proliferation during wound repair (3) and
have been shown to be the most important DETC-pro-
duced factors for keratinocyte proliferation (30). To deter-
mine whether FGFR2IIIb binding results in up-regulated
HAS 2 and 3 expression in mouse keratinocytes, recombi-
nant FGF-7 was added to PAM cells. RT-PCR revealed
that both HAS 2 and 3 are up-regulated by FGF-7 (Fig. 4
B). This correlates well with the previously published results
in rat keratinocytes (31).
To examine whether this increase in hyaluronan synthase
expression results in increased production of hyaluronan, we
cultured the keratinocytes with recombinant FGF-7 and
stained for hyaluronan using the fluorescent-labeled hyaluro-
nan binding protein. Addition of FGF-7 resulted in in-
creased hyaluronan production, even at concentrations as
low as 20 ng/ml (Fig. 5 E). The other FGFR2IIIb ligand,
FGF-10, is also produced by DETC upon TCR stimulation,
albeit at much lower levels (3; unpublished data). FGF-10
also induced hyaluronan production by keratinocytes when
added in vitro (Fig. 5 G). To determine whether kerati-
nocyte growth factors are the major DETC-produced in-
ducers of keratinocyte hyaluronan synthesis, a keratinocyte
growth factor receptor blocking peptide was added to the
transwell assays (30). This peptide is derived from a unique
region of FGFR2IIIb, and has been previously shown to
neutralize keratinocyte growth factors (30, 37). The peptide
blocked hyaluronan production by stimulated 7–17 DETC
(Fig. 5 D), whereas vehicle alone did not (Fig. 5 H). To ver-
ify the specificity of the peptide for the keratinocyte growth
factor receptor, it was used to block FGF-7–induced hyalu-
ronan production (Fig. 5 F). Taken together these results
identify keratinocyte growth factors as the major hyaluronan
inducers produced by DETC.
Activated DETC or recombinant FGF-7 induce hyaluronan 
deposition in TCR  /  skin organ culture
To investigate whether DETC-produced factors increase
hyaluronan production by keratinocytes in situ, we per-
formed organ cultures using skin from TCR  /  mice.
Skin was excised from the backs of TCR  /  mice and im-
mediately placed dermis-side down on media for 2 d. The
skin was then embedded in paraffin and sections were
stained for hyaluronan using alcian blue. We detected low
level hyaluronan deposition throughout the dermis and hy-
podermis in nonwounded skin cultured in vitro for 2 d pos-
sibly due to fibroblast activation by serum in the culture
media (Fig. 6, A and D). To examine whether DETC pro-
duce factors that stimulate hyaluronan production in cul-
tured skin tissue, resting 7–17 DETC or DETC stimulated
for 15 h with either concanavalin A or antibodies specific
for CD3 were added to the bottom of the culture dish be-
neath the TCR  /  skin. Although the presence of resting
Figure 4. DETC can express HAS genes and up-regulate keratinocyte 
HAS gene expression. The DETC cell line 7–17 expresses HAS 1 and 3 upon 
anti-CD3 stimulation (A). RT-PCR was performed on 7–17 DETC RNA iso-
lated 30 min, 1 h, and 2.5 h after stimulation. DETC induce HAS expression 
by PAM keratinocytes in transwell culture (B). Coculture of 7–17 DETC in 
the upper chamber and PAM cells in the lower chamber were performed. In 
some experiments FGF-7 was added. RT-PCR was performed on keratinocyte 
RNA isolated either before or following coculture with resting or activated 
7–17 DETC or recombinant FGF-7. cDNA was diluted 1:10 for semiquantita-
tion and compared with  -actin housekeeping gene levels. These results 
are representative of at least three separate experiments.JEM VOL. 201, April 18, 2005 1275
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DETC did not alter hyaluronan deposition compared with
TCR  /  skin alone (unpublished data), the addition of ac-
tivated DETC resulted in increased hyaluronan production,
shown as intense alcian blue staining in the dermis and
hypodermis of TCR  /  skin (Fig. 6, B and E). Diges-
tion with hyaluronidase identified the GAG as hyaluronan
(unpublished data). The results from this qualitative assay
strengthen the argument that DETC produce factors in-
volved in the induction of hyaluronan production by skin
cells. To identify whether FGF-7 induces hyaluronan depo-
sition in TCR  /  skin, recombinant FGF-7 was added to
the skin organ culture. Addition of FGF-7 increased hyalu-
ronan production in skin from TCR  /  mice (Fig. 6, C
and F). These experiments suggest that DETC are involved
in hyaluronan deposition likely via the production of kerat-
inocyte growth factors.
Figure 5. DETC-produced keratinocyte growth factors induce hyalu-
ronan production by keratinocytes. PAM keratinocytes were cultured on 
coverslips in the lower chamber of a transwell alone (A), with resting 7–17 
DETC (B), with activated 7–17 DETC (C), with 10 ng/ml FGF-7 (E), or with 
200 ng/ml FGF-10 (G). In some cases the keratinocyte growth factor recep-
tor blocking peptide at 10  g/ml (D and F) or vehicle control (H) was added. 
Cells were stained with phycoerythrin-labeled hyaluronan binding protein 
(top) and DAPI (bottom). Digital images of representative cells from at least 
three experiments were acquired at  200 magnification.DETC MODULATE GAGS TO AUGMENT INFLAMMATION | Jameson et al. 1276
Hyaluronan or FGF-7 restores macrophage recruitment to 
the wound site in    T cell–deficient mice
Macrophages migrate in response to hyaluronan injected
into the peritoneal cavity (38). We applied hyaluronan to the
wounds of TCR  /  mice in an attempt to restore macro-
phage recruitment to the wound site. Application of hyalu-
ronan directly to the excision wounds increased the levels of
hyaluronan as evidenced by increased alcian blue staining in
the wound (Fig. 7 B) and restored macrophage recruitment
to the wound site (Fig. 7, E and H). This increase in the
number of inflammatory cells entering the upper dermis
from the hypodermis indicates that hyaluronan can induce
large inflammatory infiltrates. Wild-type mice showed no
difference in macrophage migration whether or not they re-
ceived hyaluronan (Fig. S2). Thus, hyaluronan deposition in
the wound site is sufficient to allow macrophage recruitment
to the damaged region of the skin in mice lacking    T cells.
DETC isolated from the wound site produce FGF-7
within 2 d after injury (3). FGF-7 plays a key role in the in-
duction of keratinocyte-produced hyaluronan in vitro (31).
To examine the potency of FGFR2IIIb ligands in vivo we ap-
plied FGF-7 to wounds on TCR  /  mice. Consistent with
our findings in vitro, application of FGF-7 to wounds on
TCR  /  mice resulted in increased levels of hyaluronan
(Fig. 7 C) and increased numbers of macrophages homing to
the wound edge (Fig. 7, F and I). Quantitation of macro-
phages per high power field demonstrated that there were only
10   5 macrophages per field in mice receiving buffer alone,
whereas there were 43   7 macrophages per field upon addi-
tion of either KGF-1 or HA. Wild-type mice receiving KGF-1
or HA showed no differences in macrophage migration at
this time-point (Fig. S2). Taken together this data supports a
role for    T cell–produced keratinocyte growth factors in
mediating hyaluronan deposition and subsequent macrophage
migration to the wound site. Mice deficient in    T cells not
only lack    T cell–produced hyaluronan, but also the rapid
mobilization of keratinocyte growth factors to the epithelial
cells that induces keratinocyte production of hyaluronan.
DISCUSSION
   T cells are considered by many to bridge the gap between
innate and adaptive immunity. Adaptive responses by    T
cells have been well characterized including their ability to
rapidly eradicate pathogens. Less understood is the capacity
of T cells to maintain homeostasis of other cells or to repair
tissue. Recent studies have characterized the ability of    T
Figure 6. DETC or FGF-7 up-regulate hyaluronan in TCR  /  skin 
organ culture. TCR  /  back skin was cultured in media for 2 d alone 
(A and D), with activated 7–17 DETC (B and E), or FGF-7 (C and F). Shown 
are sections stained with alcian blue. The epidermis is oriented on the top 
and images represent the area directly adjacent to the wound site. Epider-
mis (e) and dermis (d) are labeled. Representative positive cells are marked 
by arrows. Digital images of representative wound sites were acquired at 
 200 (A–C) or  400 (D–F) magnification.
Figure 7. Application of hyaluronan or FGF-7 restores macrophage 
infiltration and hyaluronan deposition in TCR  /  mice. TCR  /  
mice were wounded and buffer (A, D, and G), hyaluronan (B, E, and H), or 
FGF-7 (C, F, and I) was applied topically to the wounds on days 0 and 1. 
Wounds were harvested on day 3, embedded, and stained with alcian blue 
(A–C) or with antibodies specific for F4/80 (D–I). The number of F4/80-
positive cells in the upper dermis of the skin was quantified demonstrat-
ing 10   5 positive cells per field for buffer alone and 43   7 positive 
cells per field for either KGF-1 or HA addition. The epidermis is oriented on 
the top and images represent the area directly adjacent to the wound site. 
Epidermis (e), dermis (d), and eschar (es) are labeled. Representative posi-
tive cells are marked by arrows. Digital images of representative wound 
sites were acquired at  200 (A–F) or  400 (G–I) magnification.JEM VOL. 201, April 18, 2005 1277
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cells to regulate epithelial cell proliferation or apoptosis, and
   T cell migration within a tissue as examples of T cell
maintenance of tissue homeostasis (3–5). Here we describe a
novel mechanism of tissue maintenance in which skin    T
cells regulate inflammation by modulating epithelial cell hy-
aluronan production. In this way    T cells, activated by
damaged keratinocytes, can control the timing and location
of macrophage entry into a site of epithelial injury. As such
   T cells not only regulate epithelial cell proliferation but
also have the ability to regulate epithelial cell-induced re-
cruitment of inflammatory cells to injured tissue. Our results
identify a novel mechanism used by T cells to localize in-
flammatory cells to a specific site in the tissue.
Our findings reveal a critical connection between lym-
phocytes and the ECM for the regulation of inflammation.
Inflammation is a highly dynamic process that involves many
different cell types, factors, and ECM molecules. Rapid leu-
kocyte infiltration is necessary for efficient and complete
wound healing (6–11). Once neutrophils, macrophages, and
infiltrating T cells arrive at the wound site, they can protect
against pathogens, produce proteases for tissue break-down,
secrete factors for tissue regeneration, and even produce che-
mokines to augment the inflammation. It is critical to deter-
mine which tissue-resident cell populations are involved in
this phase of wound healing. Our examination of mice lack-
ing    T cells has uncovered a key role for DETC in the re-
cruitment of macrophages to wounds.
During wound repair there is a coordinated and ordered
deposition of ECM molecules. GAGs have been implicated
in the inflammatory phase of wound repair in several capaci-
ties (for reviews see references 17, 21). One of the key roles
for GAGs involves cell adhesion. Inflammatory cells may be
tethered to the ECM adjacent to the wound site and migrate
toward the wound. This would explain why we found in-
tense staining for GAGs just beneath the wound site in wild-
type mice, where the inflammatory cells are needed. Hyalu-
ronan is a secreted GAG that is associated with early wound
repair (21). The intact hyaluronan molecule signals migrating
cells via the hyaluronan receptors CD44, ICAM-1, and
RHAMM to produce cytokines or enhance infiltration (32,
39), whereas the rapidly degraded hyaluronan binds TLR4 to
signal endothelial cells and dendritic cells to produce chemo-
kines (23, 24). Therefore, it is likely that molecules in addi-
tion to hyaluronan are also directly involved in macrophage
recruitment. Hyaluronan may also stabilize the chemokine
gradient, as has been shown for other GAGs (18), allowing
the infiltrating leukocytes to migrate in the correct direction.
The delay in macrophage entry in the   -deficient mice may
be due to decreased adhesion of macrophages to hyaluronan
in the ECM or defects in chemokine gradient maintenance.
Being an extremely hygroscopic molecule hyaluronan also
has hydrating properties that allow for cell migration (40).
Neutrophil infiltration occurs before hyaluronan deposition
in wounds from wild-type mice. Therefore the delay in hy-
aluronan production we describe in TCR  /  mice does not
result in delayed neutrophil entry. In contrast, macrophage
entry into wild-type wounds occurs by day 3, concurrent
with hyaluronan deposition. In this study we observe defects
in macrophage entry to the wound site in TCR  /  mice
that can be restored with the addition of high molecular
weight hyaluronan into the wound site. This formally dem-
onstrates that hyaluronan is a key mediator of inflammation
and macrophage migration during wound repair.
Hyaluronan is synthesized at the plasma membrane by
HAS 1–3, which have been shown to be regulated by several
different factors (31, 42). Although we found very little, if
any, hyaluronan synthase expression in the epidermis before
wound administration, by day one after wounding sustained
increases in HAS 1–3 were evident in the wild-type mouse
epidermis. There are several possible candidates for the in-
duction of hyaluronan synthesis including EGF, IGF-1, and
FGF-7. EGF is known to induce keratinocyte proliferation
(41) and up-regulate HAS 2 (42), however, it is not pro-
duced by activated DETC (unpublished results). The role of
IGF-1 in hyaluronan induction is somewhat controversial
(43, 44). However, it did not induce hyaluronan synthase
expression by PAM keratinocytes in our study. We have
previously demonstrated that DETC isolated directly from
the wound site at this time-point express FGF-7 and FGF-
10 (3). Both factors bind FGFR2IIIb (34–36) and blocking
FGFR2IIIb blocks the keratinocyte proliferation induced by
DETC coculture with keratinocytes (30). This suggests that
the major DETC-produced epithelial growth factors are ke-
ratinocyte growth factors (30). Our observations in this study
suggest that FGFR2IIIb binding factors are also necessary for
DETC-induced keratinocyte hyaluronan production. Be-
cause DETC express FGF-7 at much higher levels than
FGF-10, FGF-10 may play a redundant role in terms of the
induction of hyaluronan synthesis. Keratinocyte growth fac-
tors act in a paracrine manner, therefore keratinocytes rely
on production by cells such as DETC and fibroblasts. In this
way, DETC may act as early inducers of hyaluronan produc-
tion, thereby regulating macrophage wound infiltration.
Understanding this mechanism helps clarify the complicated
relationship between T cells and the extracellular matrix.
DETC have been shown to inhibit    T cell migration
(5) and induce epithelial cell proliferation (3) as direct mech-
anisms of cell regulation. However, in our studies we de-
scribe a regulatory role in which DETC regulate the tissue in
which they reside to support macrophage migration.    IELs
in other tissues such as the lung have also been implicated in
the initiation of inflammatory cell infiltration (45) and may
also induce epithelial hyaluronan production. Furthermore,
therapies that stimulate epithelial    T cells to rapidly pro-
duce keratinocyte growth factors and mobilize inflammatory
cells to the damaged site may be useful in patients with
wound healing complications, such as diabetics. Our findings
demonstrate a novel interaction between the immune system
and wound repair, which may aid in the development of fu-
ture therapies for chronic nonhealing wounds.DETC MODULATE GAGS TO AUGMENT INFLAMMATION | Jameson et al. 1278
MATERIALS AND METHODS
Animals and wounding procedure. TCR  /  mice on the C57Bl/6
background were purchased from the Jackson ImmunoResearch Laborato-
ries. C57Bl/6 (wild-type) and TCR  /  mice were bred at The Scripps Re-
search Institute and housed in specific pathogen-free conditions according to
the Scripps Research Institute Institutional Animal Care and Use guidelines.
Mice were used at 10–14 wk of age. Wounding was performed on mice anes-
thetized with isofluorane. In brief, the mouse backs were shaved, back skin
and panniculus carnosus was pulled up, and a sterile 3-mm punch tool was used
to create two or three sets of full-thickness wounds as described previously
(3). Wounds were left uncovered. In some experiments 50  g high molecular
weight hyaluronic acid from bovine vitreous humor (Sigma-Aldrich), 10  g
recombinant FGF-7 (Amgen), or buffer were added in 10  l to the wounds
on days 0 and 1, and wounds were harvested on day 3. These reagents all had
minimal endotoxin levels as determined by LAL test (Cambrex).
Cell lines. The DETC cell line 7–17 was maintained in complete RPMI
1640 (Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum
(Omega Scientific, Inc.) and 20 U/ml IL-2. The PAM cell line was main-
tained in complete DMEM (Invitrogen) supplemented with 10% heat-inacti-
vated fetal bovine serum. All cells were maintained in 37 C under 5% CO2.
Isolation of epidermis. Epidermis was prepared from the skin of C57Bl/6
and TCR  /  mice as described previously (3). In brief, skin from
wounded mice was excised including a 3-mm border around the wound.
Skin was incubated in a 0.3% bovine pancreatic trypsin, type XI (Sigma-
Aldrich) solution for 1–2 h at 37 C and the epidermis was separated from
the dermis and placed directly in Trizol reagent (Invitrogen).
RNA preparation and RT-PCR. Total RNA extracts were performed
in TRIzol reagent (Invitrogen) as per manufacturer’s instructions. 1  g
RNA was reverse transcribed in 30  l using reverse transcriptase (Invitro-
gen) as per manufacturers directions and 1  l cDNA was amplified using
PCR conditions previously described for HAS 1, HAS 2 (42), HAS 3, hyal-
uronidase 1–3 (33), and  -actin (3). PCR products after 35 cycles, except
 -actin at 20 cycles and HAS 2 at 31 cycles, were separated by electro-
phoresis through 1.3% agarose and visualized with ethidium bromide.
Transwell coculture of DETC and keratinocytes. 8   105 PAM ke-
ratinocytes were cultured in the bottom chamber of a 0.4- m pore size 12-
well transwell assay plate (Corning), whereas 105 DETC (cell line 7–17)
were cultured in the upper chamber insert in complete DMEM (Invitro-
gen) supplemented with 5% heat-inactivated fetal bovine serum for 7 h.
7–17 DETC were either rested in media alone or stimulated for 18 h with
antibodies specific for CD3  at 1  g/ml (500A2 clone) and washed in PBS
before addition to upper transwell. In some cases recombinant FGF-7 (Am-
gen) or FGF-10 (Cell Sciences) was added at concentrations ranging from
20 ng/ml to 50 g/ml.
Immunofluorescent staining. To examine hyaluronan production using
immunofluorescent staining, PAM keratinocytes were cultured on cover-
slips overnight to adhere in complete DMEM supplemented with 5% heat-
inactivated fetal bovine serum. Streptomyces hyaluronidase (Sigma) was
added (10 U/ml) for 30 min at 37 C before stimulation with DETC or
growth factors. Cells on coverslips were stimulated by incubation with ei-
ther 7–17 DETC in a transwell insert or recombinant growth factors for 4 h
at 37 C. Next coverslips were fixed in 4% paraformaldehyde for 20 min,
permeabilized in 0.3% Triton X-100 in PBS with 3% BSA for 20 min, in-
cubated with 3  g/ml biotinylated hyaluronan binding protein for 90 min,
washed with PBS, and subsequently incubated with 1  g/ml streptavidin–
phycoerythrin (Biomeda) for 45 min. Slides were fixed in mounting media
with DAPI (Oncogene) and digital images were acquired. In some experi-
ments keratinocyte growth factor receptor peptide inhibitor (10  g/ml) or
control vehicle (1% DMSO) were added before stimulation (30, 37). Re-
sults are representative of at least three separate experiments.
Immunohistochemistry. Mice were killed and the complete wounds in-
cluding 2 mm of the epithelial margins were excised, fixed in ethanol, and
embedded in paraffin. Sections were prepared and stained with biotinylated
antibodies to Gr-1 (BD Biosciences), CD3 (BD Biosciences), F4/80 (Cal-
tag), MHC class II (M5/114; BD Biosciences), or biotinylated hyaluronan
binding protein (Caltag) followed by peroxidase-conjugated streptavidin
(Jackson ImmunoResearch Laboratories). The presence of positive cells was
revealed by incubation in metal-enhanced DAB (Pierce chemical Co.) and
sections were counterstained with hematoxylin (Sigma-Aldrich) or nuclear
fast red (Biomeda). Slides were mounted with DPX mounting media
(Sigma-Aldrich). Control staining was done without the primary antibody
or with 10 U/ml Streptomyces hyaluronidase (Sigma-Aldrich) added before
staining. Enumeration of F4/80-positive cells was performed by counting
the number of positive cells per 1,000  high power field. At least two
wounds from each of three to five wild-type and TCR  /  mice at each
time-point were paraffin-embedded for histological analysis, immunostain-
ing, and counting. Experiments were performed at least three times.
Alcian blue staining. Paraffin sections were stained with alcian blue
(Sigma) pH 2.5 (3% acetic acid) or pH 3.1 (0.5% acetic acid) for 5 min. The
slides were counterstained with nuclear fast red (Biomeda) and mounted
with DPX mounting media. Staining was performed at least three times for
each time-point and strain of mouse. For GAG digestion, 0.5 mg/ml testic-
ular hyaluronidase (Sigma-Aldrich) or 10 U/ml Streptomyces hyaluronidase
was added for 30 min at 37 C before alcian blue staining. At least two
wounds from each of three to five wild-type and TCR  /  mice at each
time-point were paraffin-embedded for alcian blue staining.
Skin organ culture. Gel-foam (Pfizer) was soaked in complete media for
15 min on each side before addition of skin. Back skin from TCR  /  mice
was excised for culture on gel-foam in a 24-well plate in DMEM with 10%
FCS. In some cases 7–17 DETC either stimulated for 24 h by concanavalin
A (Sigma-Aldrich) or by antibodies specific for CD3  were plated at the
bottom of the well at a density of 2   105 cells per well. Recombinant
FGF-7 was added at a concentration of 50  g/ml to some wells. Skin was
harvested 2 d later, embedded for histological examination, and stained with
alcian blue.
Online supplemental material. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20042057/DC1.
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